What everyone’s missing about data quality for AI and FDA readiness
FDA's AI guidance is reshaping real-world data standards Artificial Intelligence (AI) is rapidly...
FDA's AI guidance is reshaping real-world data standards Artificial Intelligence (AI) is rapidly...
Thank you to everyone who joined us at ISPOR 2025 in Montreal. Whether you stopped by our booth,...
Traditional data aggregators are not enough The pharmaceutical industry is hitting a wall. Data...
This is part three of a three-part series on the essential qualities of claims data for life...
This is part two of a three-part series (read part 1, part 3) on the essential qualities of claims...
This is part one of a three-part series (read part 2, part 3) on the essential qualities of claims...
The problem with Zombie Data—And the critical need for Verified Data In life sciences, where...
Highlights Lab results can enhance clinical trials by providing critical data for site selection,...
In the rapidly evolving world of real-world data (RWD) for life sciences and commercial...
The one constant in healthcare marketing is change, particularly in four key areas: Evolving...
FDA's AI guidance is reshaping real-world data standards Artificial Intelligence (AI) is rapidly changing the landscape of life sciences, offering powerful tools for streamlining clinical trials, optimizing drug development, and enhancing regulatory ...